KRAS and non-small cell lung carcinoma: KRAS mutation frequently occurs in pancreatic cancer, colorectal cancer (CRC) and non-small cell lung cancer (NSCLC) and this mutation significantly restricts T cell infiltration, recruiting suppressive immune cells into the TME (35).